Previous Article | Next Article ![]()
J. Bacteriol., 04 1997, 2641-2650, Vol 179, No. 8
ML Dickens, ND Priestley and WR Strohl
We recently determined the function of the gene product of Streptomyces sp.
strain C5 doxA, a cytochrome P-450-like protein, to be daunorubicin C-14
hydroxylase (M. L. Dickens and W. R. Strohl, J. Bacteriol. 178: 3389-3395,
1996). In the present study, we show that DoxA also catalyzes the
hydroxylation of 13-deoxycarminomycin and 13- deoxydaunorubicin to
13-dihydrocarminomycin and 13-dihydrodaunorubicin, respectively, as well as
oxidizing the 13-dihydro-anthracyclines to their respective 13-keto forms.
The Streptomyces sp. strain C5 dauP gene product also was shown
unequivocally to remove the carbomethoxy group of the
epsilon-rhodomycinone-glycoside (rhodomycin D) to form 10-
carboxy-13-deoxycarminomycin. Additionally, Streptomyces sp. strain C5 DauK
was found to methylate the anthracyclines rhodomycin D, 10-carboxy-
13-deoxycarminomycin, and 13-deoxy-carminomycin, at the 4-hydroxyl
position, indicating a broader substrate specificity than was previously
known. The products of Streptomyces sp. strain C5 doxA, dauK, and dauP were
sufficient and necessary to confer on Streptomyces lividans TK24 the
ability to convert rhodomycin D, the first glycoside in daunorubicin and
doxorubicin biosynthesis, to doxorubicin.
Copyright © 1997, American Society for Microbiology
In vivo and in vitro bioconversion of epsilon-rhodomycinone glycoside to doxorubicin: functions of DauP, DauK, and DoxA
Department of Microbiology, The Ohio State University, Columbus 43210- 1292, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»